🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 16 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/03/2020 | 59,71 | 64,27 | 56,23 | 64,12 | +9,82% | 13,48% | 1.311.414 |
| 28/02/2020 | 63,08 | 65,17 | 55,22 | 58,39 | -9,44% | 15,77% | 2.213.743 |
| 27/02/2020 | 68,62 | 76,16 | 64,34 | 64,48 | +0,72% | 17,23% | 2.287.802 |
| 26/02/2020 | 62,65 | 64,25 | 61,83 | 64,02 | +3,21% | 3,86% | 546.944 |
| 25/02/2020 | 63,34 | 64,58 | 61,34 | 62,03 | -0,65% | 5,12% | 709.167 |
| 24/02/2020 | 61,30 | 63,81 | 60,67 | 62,43 | -0,65% | 5,12% | 897.520 |
| 21/02/2020 | 63,21 | 63,47 | 62,09 | 62,84 | -0,61% | 2,18% | 478.656 |
| 20/02/2020 | 63,04 | 64,39 | 62,18 | 63,23 | -0,04% | 3,49% | 445.313 |
| 19/02/2020 | 61,73 | 64,31 | 61,38 | 63,25 | +3,41% | 4,75% | 618.918 |
| 18/02/2020 | 60,66 | 61,37 | 60,20 | 61,17 | +0,84% | 1,92% | 333.424 |
| 14/02/2020 | 59,58 | 61,05 | 58,92 | 60,66 | +1,62% | 3,57% | 440.344 |
| 13/02/2020 | 59,18 | 60,21 | 58,68 | 59,69 | +0,60% | 2,59% | 485.709 |
| 12/02/2020 | 59,88 | 60,08 | 59,16 | 59,33 | +0,37% | 1,54% | 335.829 |
| 11/02/2020 | 60,17 | 60,47 | 59,08 | 59,11 | -1,64% | 2,30% | 485.388 |
| 10/02/2020 | 59,24 | 61,20 | 59,15 | 60,10 | +1,12% | 3,45% | 466.794 |
| 07/02/2020 | 59,20 | 61,99 | 57,70 | 59,43 | +3,02% | 7,24% | 1.026.241 |
| 06/02/2020 | 58,27 | 59,19 | 57,65 | 57,69 | +0,31% | 2,64% | 383.758 |
| 05/02/2020 | 56,99 | 58,51 | 56,81 | 57,51 | +2,17% | 2,99% | 600.804 |
| 04/02/2020 | 56,71 | 57,23 | 55,52 | 56,29 | +0,80% | 3,01% | 636.231 |
| 03/02/2020 | 55,96 | 57,05 | 55,70 | 55,84 | +1,94% | 2,42% | 601.766 |
| 31/01/2020 | 55,78 | 56,29 | 54,69 | 54,78 | -2,23% | 2,89% | 484.587 |
| 30/01/2020 | 55,21 | 56,13 | 54,72 | 56,03 | +0,55% | 2,56% | 349.294 |
| 29/01/2020 | 54,77 | 56,76 | 54,56 | 55,72 | +1,48% | 4,01% | 403.956 |
| 28/01/2020 | 54,44 | 55,27 | 53,61 | 54,91 | +1,71% | 3,05% | 443.710 |
| 27/01/2020 | 54,32 | 55,73 | 53,46 | 53,99 | -2,26% | 4,18% | 665.245 |
| 24/01/2020 | 56,35 | 56,51 | 54,80 | 55,23 | -1,56% | 3,03% | 549.028 |
| 23/01/2020 | 56,78 | 56,78 | 55,53 | 56,11 | -1,38% | 2,21% | 498.373 |
| 22/01/2020 | 56,06 | 57,84 | 55,85 | 56,89 | +1,60% | 3,55% | 566.180 |
| 21/01/2020 | 56,19 | 57,01 | 55,93 | 56,00 | -0,70% | 1,92% | 461.023 |
| 17/01/2020 | 58,11 | 58,16 | 55,91 | 56,39 | -2,31% | 3,88% | 504.945 |